ADHD Therapeutics Market is Witnessing High Growth by 2027 – Eli Lilly and Company, Novartis, Pfizer, GlaxoSmithKline, Mallinckrodt Pharmaceuticals
The global ADHD therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading ADHD therapeutics market players and offers key trends and opportunities in the market.
The ADHD therapeutics market is anticipated to grow in the forecast, owing to the factors such as increasing lifestyle diseases, increasing use of additives and preservations in children’s diet, and others. In addition, development of new and effective therapeutics is likely to offer growth opportunities in the market.
The key players profiled in this report are Eli Lilly and Company, Novartis, Pfizer, GlaxoSmithKline, Mallinckrodt Pharmaceuticals, Hisamitsu Pharmaceutical Co., Johnson & Johnson Services, UCB, Purdue Pharma, and Impax Laboratories.
Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPRE00003833/
Attention Deficit/Hyperactivity Disorder (ADHD) is one of the psychiatric disorder that mainly occurs in children and adolescents. The diagnosis of ADHD is difficult due to unknown genetic causes and a lack of accurate biomarkers. Psychostimulants are the primarily recommended therapeutics for the treatment of ADHD as its helps to reduce or prevent symptoms of hyperactivity, inattention, and impulsivity in order to improve quality of life.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global ADHD therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The ADHD therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting ADHD therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the ADHD therapeutics market in these regions.
Inquire for Discount: https://www.theinsightpartners.com/discount/TIPRE00003833/
The global ADHD therapeutics market is segmented on the basis of drug class, age group, distribution channel and geography. Based on drug class, the market is segmented into stimulants and non-stimulants. Based on age group, the global ADHD therapeutics market is segmented into pediatric, adolescent and adults. On the basis of distribution channel, the ADHD therapeutics market is segmented into hospital pharmacies, retail pharmacies and e-Commerce.